Emeryk Andrzej

Summary

Affiliation: Medical University of Silesia
Country: Poland

Publications

  1. doi request reprint A 12-week open-label, randomized, controlled trial and 24-week extension to assess the efficacy and safety of fluticasone propionate/formoterol in children with asthma
    Andrzej Emeryk
    Department of Paediatric Lung Diseases and Rheumatology, Medical University, Lublin, Poland
    Ther Adv Respir Dis 10:324-37. 2016
  2. doi request reprint [New dry powder inhalers]
    Andrzej Emeryk
    Pneumonol Alergol Pol 83:83-7. 2015
  3. ncbi request reprint Prevalence of asthma and some respiratory symptoms in the years 1995 and 2001 in schoolchildren from rural regions of Poland
    Andrzej Emeryk
    Department of Pulmonology and Rheumatology, University Children Hospital in Lublin, ul W Chodzki 2, 20 093 Lublin, Poland
    Ann Agric Environ Med 11:63-6. 2004
  4. ncbi request reprint [Next wheezy episode in infant--what to do?]
    Andrzej Emeryk
    Klinika Chorób Płuc i Reumatologii, Akademii Medycznej im W Skubiszewskiego w Lublinie
    Przegl Lek 64:112-4. 2007
  5. ncbi request reprint [Easyhaler--ideal dry powder inhaler]
    Emeryk Andrzej
    Uniwersytet Medyczny w Lublinie, 1Klinika Chorób Płuc i Reumatologii Dzieciqcej
    Pol Merkur Lekarski 28:307-10. 2010
  6. ncbi request reprint Fluticasone propionate 100 microg bid using a non-CFC propellant, HFA 134a, in asthmatic children
    Brian Lyttle
    Department of Paediatrics, Children s Hospital of Western Ontario, London, Canada
    Can Respir J 10:103-9. 2003
  7. ncbi request reprint Progress in pediatric allergology in 2001
    Andrzej Emeryk
    Department of Lung Diseases and Rheumatology, Medical University of Lublin, Lublin, Poland
    Ann Univ Mariae Curie Sklodowska Med 58:167-71. 2003
  8. ncbi request reprint [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma]
    Małgorzta Bartkowiak-Emeryk
    Zakład Immunologii Klinicznej Akademii Medycznej w Lublinie
    Pol Merkur Lekarski 17:5-10. 2004
  9. ncbi request reprint [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part II. Safety aspects of therapy with fluticasone propionate in asthmatic children]
    Małgorzta Bartkowiak-Emeryk
    Zakład Immunologii Klinicznej Akademii Medycznej w Lublinie
    Pol Merkur Lekarski 17:11-8. 2004
  10. ncbi request reprint [Cyclohaler's acceptance by asthma and COPD patients]
    Bernard Panaszek
    Katedra i Klinika Chorób Wewnetrznych i Alergologii Akademii Medycznej we Wrocławiu
    Pneumonol Alergol Pol 75:115-20. 2007

Collaborators

Detail Information

Publications12

  1. doi request reprint A 12-week open-label, randomized, controlled trial and 24-week extension to assess the efficacy and safety of fluticasone propionate/formoterol in children with asthma
    Andrzej Emeryk
    Department of Paediatric Lung Diseases and Rheumatology, Medical University, Lublin, Poland
    Ther Adv Respir Dis 10:324-37. 2016
    ....
  2. doi request reprint [New dry powder inhalers]
    Andrzej Emeryk
    Pneumonol Alergol Pol 83:83-7. 2015
    ..Both have been approved world wide for products used in treatment of asthma and COPD. ..
  3. ncbi request reprint Prevalence of asthma and some respiratory symptoms in the years 1995 and 2001 in schoolchildren from rural regions of Poland
    Andrzej Emeryk
    Department of Pulmonology and Rheumatology, University Children Hospital in Lublin, ul W Chodzki 2, 20 093 Lublin, Poland
    Ann Agric Environ Med 11:63-6. 2004
    ..3-17.7 %, 6.2-13.2 % and 7.6-13.3 %, respectively). These results suggest that asthma in Polish schoolchildren is still underdiagnosed...
  4. ncbi request reprint [Next wheezy episode in infant--what to do?]
    Andrzej Emeryk
    Klinika Chorób Płuc i Reumatologii, Akademii Medycznej im W Skubiszewskiego w Lublinie
    Przegl Lek 64:112-4. 2007
    ..It was emphasized the crucial role of medical history and some laboratory tests. Pharmacological and non-pharmacological methods of early intervention in wheezing neonates were also discussed...
  5. ncbi request reprint [Easyhaler--ideal dry powder inhaler]
    Emeryk Andrzej
    Uniwersytet Medyczny w Lublinie, 1Klinika Chorób Płuc i Reumatologii Dzieciqcej
    Pol Merkur Lekarski 28:307-10. 2010
    ..Currently budesonid, formoterol and salbutamol are available in Easyhaler device form. Easyhaler is accepted by majority of patients with asthma or COPD...
  6. ncbi request reprint Fluticasone propionate 100 microg bid using a non-CFC propellant, HFA 134a, in asthmatic children
    Brian Lyttle
    Department of Paediatrics, Children s Hospital of Western Ontario, London, Canada
    Can Respir J 10:103-9. 2003
    ..Secondary to phasing out chlorofluorocarbons (CFCs), the fluticasone propionate (FP) pressurized metered-dose inhaler has been formulated in a nonozone-depleting propellant, hydrofluoralkane (HFA) 134a...
  7. ncbi request reprint Progress in pediatric allergology in 2001
    Andrzej Emeryk
    Department of Lung Diseases and Rheumatology, Medical University of Lublin, Lublin, Poland
    Ann Univ Mariae Curie Sklodowska Med 58:167-71. 2003
    ....
  8. ncbi request reprint [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma]
    Małgorzta Bartkowiak-Emeryk
    Zakład Immunologii Klinicznej Akademii Medycznej w Lublinie
    Pol Merkur Lekarski 17:5-10. 2004
    ..The beneficial action of fluticasone propionate in asthma is due its anti-inflammatory properties within the airways (decreasing levels of direct and indirect markers of airways inflammations are observed)...
  9. ncbi request reprint [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part II. Safety aspects of therapy with fluticasone propionate in asthmatic children]
    Małgorzta Bartkowiak-Emeryk
    Zakład Immunologii Klinicznej Akademii Medycznej w Lublinie
    Pol Merkur Lekarski 17:11-8. 2004
    ..Effective asthma control achieved with FP therapy permits normal activity and development of asthmatic children which prevails over exceptionally noticed side effects...
  10. ncbi request reprint [Cyclohaler's acceptance by asthma and COPD patients]
    Bernard Panaszek
    Katedra i Klinika Chorób Wewnetrznych i Alergologii Akademii Medycznej we Wrocławiu
    Pneumonol Alergol Pol 75:115-20. 2007
    ..With regard to this assumption, a study was designed whose aim was to find out how patients assess a particular powder inhaler, cyclohaler and to what degree they approve of its physical and technical features...
  11. doi request reprint [Nasal allergen provocation test, allergic skin tests and serum allergen-specific IgE level in asthmatic children]
    Andrzej Emeryk
    Klinika Chorób Płuc i Reumatologii, Akademii Medycznej w Lublinie
    Otolaryngol Pol 61:617-22. 2007
    ..The important element in the asthma diagnosis is a confirmation of trigger's asthma symptoms allergens...
  12. doi request reprint The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma
    William W Busse
    Department of Medicine, University of Wisconsin School of Medicine and Public Health, J5 219 CSC, Box 2454, 600 Highland Ave, Madison, WI 53792, USA
    J Allergy Clin Immunol 121:1167-74. 2008
    ....